Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ATOSATOSSA THERAPEUTICS, INC.

Nasdaq · CIK 0001488039
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts373

Identity from submissions API

NameATOSSA THERAPEUTICS, INC.
CIK0001488039
TickersATOS
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN264753208
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone206.588.0256
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ATOSSA GENETICS INC (2010-03-30T04:00:00.000Z → 2019-11-13T05:00:00.000Z)
Business address
1448 NW MARKET STREET
SUITE 500
SEATTLE
WA
98107
WA
Mailing address
1448 NW MARKET STREET
SUITE 500
SEATTLE
WA
98107
WA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

643 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 8-K 8-K 2.02,9.01 0001193125-26-454486 001-35610 261538074 34 550716 1 1
2026-11-10 10-Q 10-Q 0001193125-26-454468 001-35610 261538032 34 6780642 1 1
2026-10-09 8-K 8-K 1.01,3.03,8.01,9.01 0001193125-26-418560 001-35610 261451179 34 566165 1 1
2026-09-29 8-K 8-K 8.01,9.01 0001193125-26-406036 001-35610 261419187 34 200683 1 1
2026-09-18 8-K 8-K 7.01,9.01 0001193125-26-395694 001-35610 261391644 34 13549314 1 1
2026-08-07 8-K 8-K 2.02,9.01 0001193125-26-339292 001-35610 261251587 34 542912 1 1
2026-08-07 10-Q 10-Q 0001193125-26-339257 001-35610 261251527 34 6408686 1 1
2026-06-12 424B5 424B5 0001193125-26-268597 333-279367 261085092 33 872012
2026-06-11 8-K 8-K 1.01,9.01 0001193125-26-266717 001-35610 261081469 34 783095 1 1
2026-05-14 4 4 0001193125-26-224521 4920
2026-05-14 4 4 0001193125-26-224148 6007
2026-05-14 4 4 0001193125-26-224140 4909
2026-05-14 4 4 0001193125-26-224135 4894
2026-05-14 4 4 0001193125-26-224133 4886
2026-05-14 4 4 0001193125-26-224125 4876
2026-05-08 8-K 8-K 9.01 0001193125-26-213439 001-35610 26956229 34 444032 1 1
2026-05-08 10-Q 10-Q 0001193125-26-213423 001-35610 26956195 34 5545528 1 1
2026-05-08 8-K 8-K 5.07 0001193125-26-213373 001-35610 26956126 34 211511 1 1
2026-04-16 8-K 8-K 8.01 0001193125-26-158030 001-35610 26865786 34 142736 1 1
2026-03-31 4 4 0001193125-26-134861 6461
2026-03-30 4 4 0001193125-26-132644 4991
2026-03-30 ARS ARS 0001193125-26-131954 001-35610 26813483 34 1137027
2026-03-30 DEF 14A DEF 14A 0001193125-26-131807 001-35610 26813238 34 8097510 1 1
2026-03-25 10-K 10-K 0001193125-26-124396 001-35610 26793582 34 8023076 1 1
2026-03-25 8-K 8-K 9.01 0001193125-26-124393 001-35610 26793566 34 345747 1 1
2026-03-20 PRE 14A PRE 14A 0001193125-26-117826 001-35610 26778880 34 4315116 1 1
2026-02-20 8-K 8-K 1.01,1.02,9.01 0001193125-26-061412 001-35610 26660255 34 410181 1 1
2026-02-20 424B5 424B5 0001193125-26-061388 333-279367 26660128 33 532076
2026-02-20 424B3 424B3 0001193125-26-061342 333-279367 26659874 33 13596
2026-02-17 8-K 8-K 3.01 0001193125-26-054797 001-35610 26642220 34 154970 1 1
2026-02-11 8-K 8-K 7.01,9.01 0001193125-26-045628 001-35610 26618527 34 304535 1 1
2026-01-30 4/A 4/A 0001193125-26-030571 8685
2026-01-26 8-K 8-K 3.03,5.03,5.07,9.01 0001193125-26-021727 001-35610 26558458 34 196114 1 1
2026-01-22 4 4 0001193125-26-019273 8344
2026-01-09 8-K 8-K 2.02,7.01,9.01 0001193125-26-008314 001-35610 26521389 34 8889071 1 1
2026-01-06 8-K 8-K 8.01,9.01 0001193125-26-003506 001-35610 26509488 34 209809 1 1
2025-12-22 DEF 14A DEF 14A 0001193125-25-327630 001-35610 251589573 34 2857885 1 1
2025-12-12 PRE 14A PRE 14A 0001193125-25-317731 001-35610 251568974 34 2020233 1 1
2025-12-04 8-K 8-K 8.01,9.01 0001193125-25-307516 001-35610 251548325 34 222728 1 1
2025-11-12 10-Q 10-Q 0001193125-25-276160 001-35610 251469424 34 6611225 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001193125-25-276140 001-35610 251469387 34 558884 1 1
2025-10-21 4 4 0001193125-25-245114 5452
2025-10-21 3 3 0001193125-25-245087 13165
2025-10-14 8-K 8-K 5.02,7.01 0001193125-25-238065 001-35610 251389689 34 375919 1 1
2025-09-26 8-K 8-K 7.01 0001193125-25-220788 001-35610 251351386 34 12800892 1 1
2025-09-08 8-K 8-K 8.01,9.01 0000950170-25-113371 001-35610 251298681 34 1169915 1 1
2025-08-21 8-K 8-K 3.01 0000950170-25-110654 001-35610 251240759 34 157460 1 1
2025-08-12 10-Q 10-Q 0000950170-25-106947 001-35610 251204260 34 6487625 1 1
2025-08-12 8-K 8-K 2.02,9.01 0000950170-25-106944 001-35610 251204245 34 544058 1 1
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000827 005-87057 251159132 34 6351
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002482 005-87057 251128412 34 10855
2025-05-22 4 4 0000950170-25-076523 6109
2025-05-16 4 4 0000950170-25-073522 5440
2025-05-16 4 4 0000950170-25-073521 5436
2025-05-16 4 4 0000950170-25-073520 5489
2025-05-16 4 4 0000950170-25-073518 5505
2025-05-16 4 4 0000950170-25-073517 5442
2025-05-16 4 4 0000950170-25-073516 5446
2025-05-16 4 4 0000950170-25-073515 5423
2025-05-16 4 4 0000950170-25-073513 5402
2025-05-13 10-Q 10-Q 0000950170-25-069827 001-35610 25937287 34 5971613 1 1
2025-05-13 8-K 8-K 2.02 0000950170-25-069818 001-35610 25937237 34 446221 1 1
2025-05-12 8-K 8-K 5.07 0000950170-25-068333 001-35610 25931991 34 218027 1 1
2025-04-07 8-K 8-K 8.01 0000950170-25-051575 001-35610 25818128 34 162527 1 1
2025-03-28 4 4 0000950170-25-046742 4813
2025-03-26 ARS ARS 0000950170-25-045327 001-35610 25773835 34 1221060
2025-03-26 DEF 14A DEF 14A 0000950170-25-045297 001-35610 25773685 34 5196181 1 1
2025-03-26 S-8 S-8 0000950170-25-045202 333-286119 25773177 33 444046 1 1
2025-03-25 10-K 10-K 0000950170-25-044099 001-35610 25765938 34 8728985 1 1
2025-03-25 8-K 8-K 2.02,9.01 0000950170-25-044098 001-35610 25765922 34 777803 1 1
2025-03-12 8-K 8-K 8.01,9.01 0000950170-25-037634 001-35610 25730119 34 259282 1 1
2025-02-24 8-K 8-K 3.01 0000950170-25-025596 001-35610 25656940 34 163593 1 1
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000035 005-87057 25601772 34 11466
2025-02-04 8-K 8-K 8.01,9.01 0000950170-25-012868 001-35610 25585618 34 538574 1 1
2024-12-10 8-K 8-K 8.01,9.01 0000950170-24-134779 001-35610 241537260 34 216101 1 1
2024-11-19 8-K 8-K 1.01 0000950170-24-128686 001-35610 241476727 34 715578 1 1
2024-11-19 424B5 424B5 0000950170-24-128656 333-279367 241476636 33 527034
2024-11-12 SC 13G/A UnitedStates_13G__AtossaTher.txt 0000932471-24-000894 005-87057 241446575 34 6665
2024-11-12 10-Q 10-Q 0000950170-24-124668 001-35610 241443763 34 6660909 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-124655 001-35610 241443730 34 806400 1 1
2024-11-08 SC 13G us04962h5063_110824.txt 0002012383-24-003546 005-87057 241439711 34 13713
2024-11-04 SC 13G/A UnitedStates_13G__AtossaTher.txt 0000932471-24-000361 005-87057 241421522 34 5708
2024-11-04 8-K 8-K 8.01 0000950170-24-120268 001-35610 241420699 34 208837 1 1
2024-10-22 SC 13G us04962h5063_102224.txt 0002012383-24-001301 005-87057 241386138 34 13701
2024-08-12 10-Q 10-Q 0000950170-24-095102 001-35610 241195124 34 6144825 1 1
2024-08-12 8-K 8-K 2.02,9.01 0000950170-24-095097 001-35610 241195102 34 796047 1 1
2024-07-02 8-K 8-K 5.02,5.03,5.07,9.01 0000950170-24-080497 001-35610 241095638 34 435724 1 1
2024-07-01 4 4 0000950170-24-079565 5449
2024-07-01 4 4 0000950170-24-079562 5459
2024-07-01 4 4 0000950170-24-079563 5408
2024-07-01 4 4 0000950170-24-079561 5445
2024-07-01 4 4 0000950170-24-079560 5516
2024-07-01 4 4 0000950170-24-079559 5498
2024-07-01 4 4 0000950170-24-079558 5451
2024-07-01 4 4 0000950170-24-079557 5432
2024-05-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-23 16:00:00 9999999995-24-001640 333-279367 24980724 33 1808
2024-05-23 DEF 14A DEF 14A 0000950170-24-063763 001-35610 24975326 34 2486405
2024-05-21 CORRESP filename1.htm 0000950170-24-062968 16626
2024-05-21 UPLOAD filename1.pdf 0000000000-24-005860 333-279367 40357
2024-05-14 DEL AM DEL AM 0001193125-24-138327 333-279367 24945261 33 12960
2024-05-13 S-3 S-3 0000950170-24-058625 333-279367 24939001 33 1409939
2024-05-13 10-Q 10-Q 0000950170-24-058244 001-35610 24937119 34 5457781 1 1
2024-05-13 8-K 8-K 2.02,9.01 0000950170-24-058242 001-35610 24937097 34 374593 1 1
2024-05-10 ARS ARS 0000950170-24-057481 001-35610 24933045 34 849905
2024-05-10 PRE 14A PRE 14A 0000950170-24-057478 001-35610 24933030 34 2487891
2024-04-11 4 4 0000950170-24-043690 4905
2024-04-02 8-K/A 8-K/A 2.02,9.01 0000950170-24-039634 001-35610 24811721 34 379000 1 1
2024-04-01 10-K 10-K 0000950170-24-039306 001-35610 24809129 34 7971380 1 1
2024-04-01 8-K 8-K 2.02,9.01 0000950170-24-039286 001-35610 24808965 34 378304 1 1
2024-03-18 8-K 8-K 3.01 0000950170-24-032535 001-35610 24757009 34 155756 1 1
2024-03-14 4 4 0000950170-24-031815 5274
2024-03-14 3 3 0000950170-24-031813 12376
2024-03-12 8-K 8-K 5.02,7.01,9.01 0000950170-24-029671 001-35610 24740285 34 182633 1 1
2023-11-17 4 FORM 4 0001437749-23-032461 4238
2023-11-15 4/A FORM 4/A 0001437749-23-032191 5064
2023-11-15 3 FORM 3 0001437749-23-032174 9910
2023-11-15 4 FORM 4 0001437749-23-032166 4982
2023-11-13 10-Q FORM 10-Q 0001437749-23-031424 001-35610 231395694 34 4960097 1 1
2023-11-13 8-K FORM 8-K 2.02,9.01 0001437749-23-031420 001-35610 231395582 34 322129 1 1
2023-11-09 8-K FORM 8-K 5.02 0001437749-23-031085 001-35610 231390283 34 153486 1 1
2023-10-16 3 FORM 3 0001437749-23-028277 16943
2023-10-06 8-K FORM 8-K 5.02 0001437749-23-027849 001-35610 231314198 34 153144 1 1
2023-09-28 8-K FORM 8-K 3.01 0001437749-23-027048 001-35610 231290098 34 155930 1 1
2023-08-31 8-K FORM 8-K 8.01 0001437749-23-024896 001-35610 231226604 34 152180 1 1
2023-08-14 10-Q FORM 10-Q 0001437749-23-023426 001-35610 231166529 34 5226333 1 1
2023-08-14 8-K FORM 8-K 2.02,9.01 0001437749-23-023423 001-35610 231166498 34 271743 1 1
2023-07-13 8-K FORM 8-K 3.01 0001437749-23-019877 001-35610 231086988 34 153435 1 1
2023-06-28 8-K FORM 8-K 7.01,9.01 0001437749-23-018677 001-35610 231049506 34 169902 1 1
2023-06-23 8-K FORM 8-K 3.01 0001437749-23-018173 001-35610 231034957 34 153387 1 1
2023-06-20 4 FORM 4 0001437749-23-017896 5026
2023-06-05 4 FORM 4 0001437749-23-016569 5209
2023-06-01 8-K FORM 8-K 5.02 0001437749-23-016319 001-35610 23983217 34 156867 1 1
2023-05-22 8-K FORM 8-K 4.01,9.01 0001437749-23-015468 001-35610 23944553 34 164832 1 1
2023-05-15 10-Q FORM 10-Q 0001437749-23-014366 001-35610 23918941 34 4730251 1 1
2023-05-15 8-K FORM 8-K 2.02,9.01 0001437749-23-014365 001-35610 23918887 34 267006 1 1
2023-05-05 4 FORM 4 0001437749-23-012872 5096
2023-05-05 4 FORM 4 0001437749-23-012871 5124
2023-05-05 4 FORM 4 0001437749-23-012870 5076
2023-05-05 4 FORM 4 0001437749-23-012869 5117
2023-05-05 4 FORM 4 0001437749-23-012868 5122
2023-05-04 8-K FORM 8-K 5.07 0001437749-23-012579 001-35610 23889061 34 163381 1 1
2023-04-26 DEFA14A FORM DEFA14A 0001437749-23-011163 001-35610 23850489 34 25540
2023-04-26 8-K FORM 8-K 5.03,9.01 0001437749-23-011141 001-35610 23849812 34 283420 1 1
2023-04-04 8-K FORM 8-K 3.01 0001437749-23-009194 001-35610 23795865 34 153029 1 1
2023-03-30 ARS formars.pdf 0001437749-23-008662 001-35610 23781711 34 1600230
2023-03-30 DEF 14A FORM DEF 14A 0001437749-23-008515 001-35610 23777275 34 1153456
2023-03-22 10-K FORM 10-K 0001437749-23-007531 001-35610 23753029 34 5964311 1 1
2023-03-22 8-K FORM 8-K 2.02,9.01 0001437749-23-007529 001-35610 23752945 34 265772 1 1
2023-03-13 8-K FORM 8-K 8.01 0001437749-23-006304 001-35610 23725928 34 151132 1 1
2023-03-06 4 FORM 4 0001437749-23-005533 5002
2023-03-06 4 FORM 4 0001437749-23-005531 4982
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015384 005-87057 23602518 34 13006
2022-11-07 10-Q FORM 10-Q 0001437749-22-026178 001-35610 221365398 34 5146146 1 1
2022-11-07 8-K FORM 8-K 2.02,9.01 0001437749-22-026177 001-35610 221365322 34 265133 1 1
2022-10-07 8-K FORM 8-K 3.01 0001437749-22-023831 001-35610 221300910 34 152877 1 1
2022-08-08 10-Q FORM 10-Q 0001437749-22-019359 001-35610 221144353 34 4544517 1 1
2022-08-08 8-K FORM 8-K 2.02,9.01 0001437749-22-019352 001-35610 221144206 34 297959 1 1
2022-07-08 SC 13G us04962h5063_070822.txt 0000834237-22-010353 005-87057 221075111 34 12276
2022-07-07 8-K FORM 8-K 8.01 0001437749-22-016816 001-35610 221071762 34 153760 1 1
2022-07-01 8-K FORM 8-K 7.01 0001437749-22-016412 001-35610 221059859 34 154698 1 1
2022-06-06 8-K FORM 8-K 7.01 0001437749-22-014377 001-35610 22997706 34 159592 1 1
2022-05-16 4 FORM 4 0001437749-22-012713 5067
2022-05-16 4 FORM 4 0001437749-22-012712 5072
2022-05-16 4 FORM 4 0001437749-22-012711 5074
2022-05-16 4 FORM 4 0001437749-22-012710 5027
2022-05-16 4 FORM 4 0001437749-22-012709 5046
2022-05-16 8-K FORM 8-K 5.07 0001437749-22-012483 001-35610 22925862 34 178961 1 1
2022-05-09 10-Q FORM 10-Q 0001437749-22-011508 001-35610 22904906 34 4112914 1 1
2022-05-09 8-K FORM 8-K 2.02,9.01 0001437749-22-011504 001-35610 22904770 34 236318 1 1
2022-04-11 DEF 14A FORM DEF 14A 0001437749-22-008682 001-35610 22819729 34 1423178
2022-04-01 PRE 14A FORM PRE 14A 0001437749-22-008033 001-35610 22798085 34 1424004
2022-02-28 4 FORM 4 0001437749-22-004668 4944
2022-02-28 4 FORM 4 0001437749-22-004667 4960
2022-02-28 10-K FORM 10-K 0001437749-22-004614 001-35610 22689591 34 6965088 1 1
2022-02-28 8-K FORM 8-K 2.02,5.02,9.01 0001437749-22-004608 001-35610 22689372 34 254481 1 1
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022506 005-87057 22630326 34 58010
2022-02-09 SC 13G SCHEDULE 13G 0001104659-22-016561 005-87057 22606473 34 12978
2022-02-04 SC 13G us04962h5063_020422.txt 0000834237-22-007196 005-87057 22593449 34 13203
2022-01-13 SC 13G/A ATOSSA THERAPEUTICS, INC. 0000902664-22-000208 005-87057 22528168 34 73900
2021-11-15 10-Q FORM 10-Q 0001437749-21-026640 001-35610 211406928 34 5005935 1 1
2021-11-15 8-K FORM 8-K 2.02,9.01 0001437749-21-026637 001-35610 211406871 34 255831 1 1
2021-10-06 8-K FORM 8-K 5.07 0001437749-21-023371 001-35610 211310162 34 153010 1 1
2021-09-14 DEFA14A FORM DEFA14A 0001437749-21-022109 001-35610 211252530 34 43236
2021-09-08 8-K FORM 8-K 5.07 0001437749-21-021611 001-35610 211240662 34 153184 1 1
2021-08-13 10-Q FORM 10-Q 0001437749-21-019810 001-35610 211170029 34 4901171 1 1
2021-08-13 8-K FORM 8-K 2.02,9.01 0001437749-21-019809 001-35610 211170009 34 258804 1 1
2021-08-09 DEF 14A FORM DEF 14A 0001437749-21-019134 001-35610 211156341 34 893921
2021-07-29 PRE 14A FORM PRE 14A 0001437749-21-017871 001-35610 211127314 34 893923
2021-07-07 4 FORM 4 0001437749-21-016573 20470
2021-05-18 8-K FORM 8-K 5.02,5.07 0001437749-21-012685 001-35610 21936624 34 46092
2021-05-18 4 FORM 4 0001437749-21-012678 5076
2021-05-18 4 FORM 4 0001437749-21-012676 5141
2021-05-18 4 FORM 4 0001437749-21-012675 5122
2021-05-18 4 FORM 4 0001437749-21-012677 5071
2021-05-18 4 FORM 4 0001437749-21-012674 5141
2021-05-18 4 FORM 4 0001437749-21-012673 5078
2021-05-18 4 FORM 4 0001437749-21-012671 5050
2021-05-18 4 FORM 4 0001437749-21-012672 5030
2021-05-14 10-Q FORM 10-Q 0001437749-21-012213 001-35610 21922310 34 3649255 1
2021-05-14 8-K FORM 8-K 2.02,9.01 0001437749-21-012205 001-35610 21922180 34 103188
2021-05-11 DEFA14A FORM DEFA14A 0001437749-21-011692 001-35610 21911314 34 29015
2021-04-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-04-29 16:00:00 9999999995-21-001636 333-255411 21873511 33 1759
2021-04-27 CORRESP filename1.htm 0001437749-21-009907 14097
2021-04-26 UPLOAD filename1.pdf 0000000000-21-005268 40270
2021-04-21 S-3 FORM S-3 0001437749-21-009473 333-255411 21841843 33 306927
2021-04-15 DEF 14A FORM DEF 14A 0001437749-21-009021 001-35610 21828477 34 673612
2021-04-05 PRE 14A FORM PRE 14A 0001437749-21-008212 001-35610 21805340 34 677830
2021-03-31 S-8 FORM S-8 0001437749-21-007791 333-254905 21792513 33 204105
2021-03-31 10-K FORM 10-K 0001437749-21-007756 001-35610 21790061 34 5864674 1
2021-03-31 8-K FORM 8-K 2.02,9.01 0001437749-21-007755 001-35610 21790047 34 110164
2021-03-23 424B5 FORM 424B5 0001437749-21-006841 333-248555 21763129 33 387160
2021-03-23 8-K FORM 8-K 1.01,9.01 0001437749-21-006835 001-35610 21763041 34 565830
2021-03-22 S-3MEF FORM S-3MEF 0001437749-21-006677 333-254548 21759908 33 91625
2021-03-22 8-K FORM 8-K 1.02 0001437749-21-006671 001-35610 21759871 34 24359
2021-02-04 424B2 FORM 424B2 0001437749-21-002008 333-252335 21591338 33 197144
2021-01-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-01-29 16:00:00 9999999995-21-000358 333-252335 21574131 33 1759
2021-01-28 CORRESP filename1.htm 0001437749-21-001456 15723
2021-01-28 UPLOAD filename1.pdf 0000000000-21-001055 40247
2021-01-22 S-3 FORM S-3 0001437749-21-001081 333-252335 21545833 33 325346
2021-01-15 SC 13G SCHEDULE 13G 0001213900-21-002530 005-87057 21532182 34 61948
2021-01-15 SC 13G SC 13G 0001104659-21-004559 005-87057 21530960 34 76666
2021-01-15 SC 13G/A SC 13G/A 0001104659-21-004558 005-87057 21530957 34 68617
2021-01-14 SC 13G ATOSSA THERAPEUTICS, INC. 0000902664-21-000205 005-87057 21527575 34 78984
2021-01-08 424B3 FORM 424B3 0001437749-21-000378 333-248555 21515868 33 428636
2021-01-08 8-K FORM 8-K 1.01,9.01 0001437749-21-000377 001-35610 21515828 34 489818
2020-12-28 SC 13G SCHEDULE 13G 0001213900-20-044585 005-87057 201414486 34 75513
2020-12-21 424B5 FORM 424B5 0001437749-20-025664 333-248555 201402634 33 421066
2020-12-21 8-K FORM 8-K 1.01,9.01 0001437749-20-025663 001-35610 201402614 34 506059
2020-12-18 SC 13G SC 13G 0001104659-20-137258 005-87057 201398661 34 72902
2020-12-14 8-K FORM 8-K 1.01,9.01 0001437749-20-025295 001-35610 201386337 34 422125
2020-12-11 424B3 FORM 424B3 0001437749-20-025138 333-250820 201382241 33 222538
2020-12-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-12-08 17:00:00 9999999995-20-003444 333-250820 201376817 33 1760
2020-12-08 8-K FORM 8-K 9.01 0001437749-20-024985 001-35610 201375704 34 337899
2020-12-07 CORRESP filename1.htm 0001437749-20-024928 9146
2020-12-07 CORRESP filename1.htm 0001437749-20-024927 15698
2020-12-01 S-1/A FORM S-1/A 0001437749-20-024667 333-250820 201361778 33 1057291
2020-11-30 8-K FORM 8-K 8.01 0001437749-20-024533 001-35610 201356355 34 21796
2020-11-27 UPLOAD filename1.pdf 0000000000-20-011390 40121
2020-11-20 S-1 FORM S-1 0001437749-20-024290 333-250820 201332826 33 389407
2020-11-13 10-Q FORM 10-Q 0001437749-20-023747 001-35610 201309469 34 3891945 1
2020-11-13 8-K FORM 8-K 2.02,9.01 0001437749-20-023746 001-35610 201309461 34 167006
2020-09-25 8-K FORM 8-K 1.01,9.01 0001437749-20-020267 001-35610 201200808 34 239342
2020-09-25 424B3 FORM 424B3 0001437749-20-020266 333-248555 201200801 33 361204
2020-09-10 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-09-10 16:00:00 9999999995-20-002415 333-248555 201169848 33 1760
2020-09-08 UPLOAD filename1.pdf 0000000000-20-008409 40329
2020-09-08 CORRESP filename1.htm 0001437749-20-019381 17530
2020-09-02 S-3 FORM S-3 0001437749-20-019223 333-248555 201157067 33 896001
2020-08-13 10-Q FORM 10-Q 0001437749-20-017738 001-35610 201097609 34 3691789 1
2020-08-13 8-K FORM 8-K 2.02,9.01 0001437749-20-017737 001-35610 201097551 34 170624
2020-05-19 4 FORM 4 0001437749-20-011265 5078
2020-05-19 4 FORM 4 0001437749-20-011264 5050
2020-05-19 4 FORM 4 0001437749-20-011263 5030
2020-05-19 4 FORM 4 0001437749-20-011262 5071
2020-05-19 4 FORM 4 0001437749-20-011261 5076
2020-05-19 8-K FORM 8-K 5.07 0001437749-20-011257 001-35610 20892895 34 42768
2020-05-13 10-Q FORM 10-Q 0001437749-20-010514 001-35610 20871345 34 3313902 1
2020-05-13 8-K FORM 8-K 2.02,9.01 0001437749-20-010512 001-35610 20871330 34 142454
2020-04-13 4 FORM 4 0001437749-20-007630 7587
2020-04-13 4 FORM 4 0001437749-20-007628 7606
2020-04-13 8-K FORM 8-K 5.02,9.01 0001437749-20-007600 001-35610 20788962 34 62266
2020-04-13 DEF 14A FORM DEF 14A 0001437749-20-007556 001-35610 20788172 34 1177143
2020-03-26 10-K FORM 10-K 0001437749-20-006155 001-35610 20744241 34 4879972 1
2020-03-26 8-K FORM 8-K 2.02,9.01 0001437749-20-006154 001-35610 20744226 34 153431
2020-02-10 8-K FORM 8-K 1.01,9.01 0001437749-20-002085 001-35610 20588608 34 239462
2020-02-07 424B3 FORM 424B3 0001437749-20-002083 333-220572 20588487 33 373314
2020-01-07 8-K FORM 8-K 5.03,9.01 0001437749-20-000245 001-35610 20511459 34 144639
2019-11-13 8-K FORM 8-K 2.02,9.01 0001437749-19-022614 001-35610 191211852 34 175654
2019-11-13 10-Q FORM 10-Q 0001437749-19-022613 001-35610 191211844 34 3500668 1
2019-10-15 8-K FORM 8-K 8.01 0001437749-19-020029 001-35610 191150308 34 29070
2019-08-13 8-K FORM 8-K 2.02,9.01 0001437749-19-016451 001-35610 191018314 34 214626
2019-08-13 10-Q FORM 10-Q 0001437749-19-016448 001-35610 191018310 34 3518311 1
2019-06-27 8-K FORM 8-K 7.01,9.01 0001437749-19-012879 001-35610 19923985 34 54957
2019-05-21 4 FORM 4 0001437749-19-010648 4936
2019-05-21 4 FORM 4 0001437749-19-010647 4916
2019-05-21 4 FORM 4 0001437749-19-010646 4962
2019-05-21 4 FORM 4 0001437749-19-010645 4964
2019-05-21 4 FORM 4 0001437749-19-010644 4957
2019-05-17 8-K FORM 8-K 5.02,5.07 0001437749-19-010399 001-35610 19836146 34 50112
2019-05-13 10-Q FORM 10-Q 0001437749-19-009666 001-35610 19818821 34 2934142 1
2019-05-13 8-K FORM 8-K 2.02,9.01 0001437749-19-009664 001-35610 19818787 34 164999
2019-04-12 DEF 14A FORM DEF 14A 0001437749-19-007053 001-35610 19745668 34 1007109
2019-03-28 10-K FORM 10-K 0001437749-19-005927 001-35610 19712414 34 6281561 1
2019-03-28 8-K FORM 8-K 2.02,9.01 0001437749-19-005929 001-35610 19712413 34 165099
2019-02-08 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-19-001898 005-87057 19579080 34 88167
2019-01-15 4 FORM 4 0001615774-19-000645 8326
2019-01-15 8-K FORM 8-K 5.02,9.01 0001437749-19-000870 001-35610 19527229 34 178967
2019-01-15 4 FORM 4 0001615774-19-000644 8343
2018-11-14 10-Q FORM 10-Q 0001437749-18-020638 001-35610 181179636 34 3721522 1
2018-11-13 8-K FORM 8-K 2.02,4.02,9.01 0001437749-18-020569 001-35610 181178042 34 225887
2018-11-13 10-Q/A FORM 10-Q/A 0001615774-18-012549 001-35610 181177967 34 2540659 1
2018-09-13 8-K 8-K 7.01,8.01,9.01 0001615774-18-009490 001-35610 181067994 34 2850332
2018-08-13 10-Q 10-Q 0001615774-18-007923 001-35610 181012489 34 2389555 1
2018-08-13 8-K 8-K 2.02,9.01 0001615774-18-007922 001-35610 181012467 34 95857
2018-07-03 8-K 8-K 5.02,9.01 0001615774-18-006119 001-35610 18934675 34 53295
2018-06-29 4 4 0001615774-18-006001 5299
2018-06-29 4 4 0001615774-18-006000 5167
2018-06-29 4 4 0001615774-18-005998 5119
2018-06-29 4 4 0001615774-18-005997 5293
2018-06-29 4 4 0001615774-18-005996 5160
2018-06-29 4 4 0001615774-18-005995 5165
2018-06-29 4 4 0001615774-18-005994 5139
2018-06-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2018-06-14 16:00:00 9999999995-18-001509 333-225424 18900648 33 1651
2018-06-12 UPLOAD filename1.pdf 0000000000-18-018066 44684
2018-06-12 CORRESP filename1.htm 0001615774-18-005158 8227
2018-06-04 S-1 FORM S-1 0001615774-18-004829 333-225424 18879157 33 235172
2018-05-31 4 OWNERSHIP DOCUMENT 0001615774-18-004659 8956
2018-05-31 4 OWNERSHIP DOCUMENT 0001615774-18-004657 8956
2018-05-31 4 OWNERSHIP DOCUMENT 0001615774-18-004655 8231
2018-05-31 8-K FORM 8K 3.03,5.03,8.01,9.01 0001615774-18-004587 001-35610 18869966 34 361917
2018-05-17 8-K FORM 8K 2.02,9.01 0001615774-18-003978 001-35610 18842273 34 103206
2018-05-16 FWP FWP 0001615774-18-003930 333-223949 18839712 34 8746346
2018-05-14 10-Q FORM 10-Q 0001615774-18-003668 001-35610 18828817 34 1972863 1
2018-05-10 424B4 424B4 0001615774-18-003583 333-223949 18823985 33 425464
2018-05-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2018-05-09 17:00:00 9999999995-18-001185 333-223949 18820291 33 1651
2018-05-07 CORRESP filename1.htm 0001615774-18-003391 8386
2018-05-07 CORRESP filename1.htm 0001615774-18-003390 8697
2018-05-03 CORRESP filename1.htm 0001615774-18-003229 19774
2018-05-03 S-1/A S-1/A 0001615774-18-003227 333-223949 18801866 33 661557
2018-04-27 SC 13G SCHEDULE 13G 0001213900-18-005062 005-87057 18784167 34 60146
2018-04-25 UPLOAD filename1.pdf 0000000000-18-012803 46994
2018-04-23 CORRESP filename1.htm 0001615774-18-002815 16034
2018-04-23 S-1/A FORM S-1 0001615774-18-002813 333-223949 18768071 33 1217888
2018-04-23 8-K FORM 8-K 3.03,5.03,5.07,9.01 0001615774-18-002808 001-35610 18767896 34 46938
2018-04-17 8-K FORM 8-K 5.07 0001615774-18-002666 001-35610 18757547 34 38405
2018-04-16 DEFA14A SCHEDULE 14A 0001615774-18-002644 001-35610 18755473 34 53891
2018-04-06 UPLOAD filename1.pdf 0000000000-18-010515 47190
2018-04-02 DEFA14A DEFA14A 0001615774-18-002285 001-35610 18728890 34 23336
2018-03-27 S-1 S-1 0001615774-18-002120 333-223949 18715570 33 507641
2018-03-20 DEF 14A DEF 14A 0001615774-18-001985 001-35610 18700615 34 1007854
2018-03-08 PRE 14A PRE 14A 0001615774-18-001705 001-35610 18677444 34 849755
2018-03-08 10-K 10-K 0001615774-18-001693 001-35610 18676533 34 4479043 1
2018-03-08 8-K 8-K 2.02,9.01 0001615774-18-001692 001-35610 18676489 34 117698
2018-02-21 8-K 8-K 7.01,8.01,9.01 0001615774-18-001342 001-35610 18627008 34 8963953
2018-02-14 SC 13G/A c90516_sc13ga.htm 0000930413-18-000510 005-87057 18613961 34 52867
2018-02-01 8-K 8-K 7.01,8.01,9.01 0001615774-18-000770 001-35610 18566868 34 7191973
2018-01-19 SC 13G/A EMPERY ASSET MANAGEMENT, LP 0000902664-18-000311 005-87057 18537335 34 48348
2017-12-22 8-K 8-K 1.01,3.02,9.01 0001615774-17-007555 001-35610 171272415 34 581534
2017-12-21 424B5 424B5 0001615774-17-007507 333-220572 171268925 33 440835
2017-11-16 4 OWNERSHIP DOCUMENT 0001615774-17-006777 5976
2017-11-14 8-K 8-K 2.02,9.01 0001615774-17-006627 001-35610 171198613 34 119599
2017-11-13 10-Q 10-Q 0001615774-17-006519 001-35610 171195787 34 3498684 1
2017-11-09 SC 13G c89706_sc13g.htm 0000930413-17-003736 005-87057 171190635 34 57989
2017-11-03 SC 13G/A SCHEDULE 13G 0001553350-17-001167 005-87057 171177156 34 33538
2017-11-03 SC 13G SCHEDULE 13G 0001553350-17-001165 005-87057 171177084 34 33313
2017-10-31 SC 13G ATOSSA GENETICS INC. 0000902664-17-004121 005-87057 171165457 34 80310
2017-10-30 8-K FORM 8-K 1.01,8.01,9.01 0001615774-17-005989 001-35610 171162454 34 379067
2017-10-27 424B3 424B3 0001615774-17-005964 333-220572 171159475 33 429862
2017-10-26 424B3 424B3 0001615774-17-005904 333-220572 171154133 33 427947
2017-10-25 8-K 8-K 7.01,8.01,9.01 0001615774-17-005890 001-35610 171152206 34 12793085
2017-10-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2017-10-05 16:00:00 9999999995-17-002602 333-220572 171125703 33 1652
2017-10-03 CORRESP filename1.htm 0001615774-17-005517 8785
2017-10-03 UPLOAD filename1.pdf 0000000000-17-035048 135511
2017-09-22 S-3 S-3 0001615774-17-005291 333-220572 171097686 33 1503791
2017-09-14 8-K 8-K 7.01,8.01,9.01 0001615774-17-005084 001-35610 171085264 34 3662119
2017-08-14 10-Q 10-Q 0001615774-17-004407 001-35610 171031606 34 3505454 1
2017-08-14 8-K 8-K 2.02,9.01 0001615774-17-004385 001-35610 171031231 34 103863
2017-07-03 424B3 424B3 0001615774-17-003470 333-216031 17945190 33 7701
2017-06-30 8-K 8-K 3.03,9.01 0001615774-17-003423 001-35610 17940535 34 64630
2017-06-02 8-K 8-K 3.01 0001615774-17-002895 001-35610 17887198 34 17640
2017-05-26 4 OWNERSHIP DOCUMENT 0001615774-17-002749 5171
2017-05-26 4 OWNERSHIP DOCUMENT 0001615774-17-002747 5151
2017-05-26 4 OWNERSHIP DOCUMENT 0001615774-17-002745 5541
2017-05-26 4 OWNERSHIP DOCUMENT 0001615774-17-002743 5196
2017-05-26 4 OWNERSHIP DOCUMENT 0001615774-17-002741 5204
2017-05-26 4 4 0001615774-17-002739 5174
2017-05-26 4 OWNERSHIP DOCUMENT 0001615774-17-002737 5185
2017-05-11 8-K 8-K 2.02,3.01,5.07,9.01 0001615774-17-002265 001-35610 17835429 34 82853
2017-05-11 10-Q 10-Q 0001615774-17-002259 001-35610 17835403 34 2531383 1
2017-04-18 4 4 0001615774-17-001757 4912
2017-04-13 DEF 14A DEF 14A 0001615774-17-001655 001-35610 17759222 34 623050
2017-04-04 8-K 8-K 1.01,9.01 0001615774-17-001473 001-35610 17736139 34 377005
2017-03-31 424B3 424B3 0001615774-17-001393 333-216031 17729646 33 182142
2017-03-30 FWP FWP 0001615774-17-001327 333-216031 17723668 34 24578
2017-03-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2017-03-28 17:00:00 9999999995-17-000676 333-216031 17720575 33 1728
2017-03-28 S-1/A S-1/A 0001615774-17-001284 333-216031 17719213 33 322577
2017-03-28 CORRESP filename1.htm 0001615774-17-001279 21388
2017-03-28 CORRESP filename1.htm 0001615774-17-001277 9408
2017-03-28 S-1/A S-1/A 0001615774-17-001273 333-216031 17718085 33 563045
2017-03-23 CORRESP filename1.htm 0001615774-17-001205 10975
2017-03-23 S-1/A S-1/A 0001615774-17-001190 333-216031 17708085 33 457000
2017-03-22 CORRESP filename1.htm 0001615774-17-001184 9584
2017-03-21 FWP FWP 0001615774-17-001161 333-216031 17702971 34 6293005
2017-03-21 S-1/A S-1/A 0001615774-17-001159 333-216031 17702967 33 318433
2017-03-21 10-Q/A 10-Q/A 0001615774-17-001158 001-35610 17702965 34 2547880 1
2017-03-21 10-Q/A 10-Q/A 0001615774-17-001155 001-35610 17702964 34 2899035 1
2017-03-21 10-Q/A 10-Q/A 0001615774-17-001154 001-35610 17702963 34 2947589 1
2017-03-21 10-K/A 10-K/A 0001615774-17-001151 001-35610 17702952 34 4771705 1
2017-03-16 S-1/A S-1/A 0001615774-17-001094 333-216031 17694843 33 291787
2017-03-16 10-K 10-K 0001615774-17-001088 001-35610 17694594 34 4661793 1
2017-02-13 S-1 S-1 0001144204-17-007884 333-216031 17599014 33 505529
2016-12-12 8-K 8-K 8.01,9.01 0001144204-16-138832 001-35610 162045240 34 194836
2016-11-14 8-K FORM 8-K 2.02,9.01 0001144204-16-134206 001-35610 161995056 34 90259
2016-11-14 10-Q 10-Q 0001144204-16-134190 001-35610 161994964 34 3531036 1
2016-09-02 8-K FORM 8-K 1.01,8.01,9.01 0001144204-16-122715 001-35610 161869133 34 302163
2016-09-01 424B5 424B5 0001144204-16-122559 333-192390 161866558 33 337139
2016-08-31 424B3 424B3 0001144204-16-122172 333-192390 161861797 33 339086
2016-08-26 8-K FORM 8-K 3.03,5.03,9.01 0001144204-16-121498 001-35610 161855087 34 52814
2016-08-23 8-K FORM 8-K 7.01,8.01 0001144204-16-120688 001-35610 161846844 34 16557
2016-08-12 10-Q FORM 10-Q 0001144204-16-118486 001-35610 161826267 34 3280547 1
2016-08-12 8-K FORM 8-K 2.02,9.01 0001144204-16-118485 001-35610 161826254 34 89287

Latest XBRL company facts

One latest value per concept from companyfacts (373 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 9.98M 2026-07-31 2026 Q2 10-Q 2026-08-07 0001193125-26-339257
dei EntityPublicFloat Entity Public Float USD 107.15M 2025-06-30 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 4,040 2017-09-30 2017 Q3 10-Q 2017-11-13 0001615774-17-006519
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 1.06M 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064686
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 831,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 0 2021-09-30 2021 Q3 10-Q 2021-11-15 0001437749-21-026640
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 66,048 2016-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 504,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 89,882 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064686
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AccruedSalesCommissionCurrent Accrued Sales Commission, Current USD 737,991 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064686
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 186,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 16,000 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -54,000 2022-09-30 2022 Q3 10-Q 2022-11-07 0001437749-22-026178
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 291.70M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 254.89M 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap AdditionalPaidInCapitalPreferredStock Additional Paid in Capital, Preferred Stock USD 625,999 2020-06-30 2020 Q2 10-Q 2020-08-13 0001437749-20-017738
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD -1.28M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-28 0001437749-19-005927
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -42,864 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 926,000 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 501,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 4.12M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001144204-15-046909
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 1.18M 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064686
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 59,556 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001437749-18-020638
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 27,600 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001437749-21-007756
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap Assets Assets USD 26.45M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AssetsCurrent Assets, Current USD 25.18M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 76,025 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap CapitalizedComputerSoftwareGross Capitalized Computer Software, Gross USD 113,540 2016-09-30 2016 Q3 10-Q 2016-11-14 0001144204-16-134190
us-gaap CapitalLeasedAssetsGross Capital Leased Assets, Gross USD 206,702 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 0 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064686
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 125,241 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 76,025 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 0 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 0 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 0 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 49,216 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 400,000 2012-01-01 2012-09-30 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 20.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 4.19M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 15.29M 2018-06-30 2018 Q2 10-Q/A 2018-11-13 0001615774-18-012549
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 20.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -20.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2018-06-30 2018 Q2 10-Q/A 2018-11-13 0001615774-18-012549
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD -157,684 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD -2.63M 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 93.87M 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 2.77M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 4.32M 2018-09-30 2018 Q3 10-Q 2018-11-14 0001437749-18-020638
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.18 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 350.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 9.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 9.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap CommonStockValue Common Stock, Value, Issued USD 1.80M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -22.34M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 5,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 48,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001437749-20-023747
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 10,107 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001437749-18-020638
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 1,333.33 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 132,411 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap CostOfRevenue Cost of Revenue USD 132,411 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap CostOfServices Cost of Services (Deprecated 2018-01-31) USD 1.21M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030135
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap DeferredCompensationShareBasedArrangementsLiabilityCurrent Deferred Compensation Share-based Arrangements, Liability, Current USD 1.41M 2018-12-31 2019 FY 10-K 2020-03-26 0001437749-20-006155
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 1.03M 2018-12-31 2019 FY 10-K 2020-03-26 0001437749-20-006155
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 541 2020-12-31 2020 FY 10-K 2021-03-31 0001437749-21-007756
us-gaap DeferredTaxAssetsEquityMethodInvestments Deferred Tax Assets, Equity Method Investments USD 987,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 113,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 36.82M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 27,554 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 30.09M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 49.40M 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 34.10M 2020-12-31 2020 FY 10-K 2021-03-31 0001437749-21-007756
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 98,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 0 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Compensated Absences USD 45,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses USD 5,593 2019-12-31 2020 FY 10-K 2021-03-31 0001437749-21-007756
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.89M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 143,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses USD 33,241 2018-12-31 2018 FY 10-K 2019-03-28 0001437749-19-005927
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 36.82M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap DeferredTaxAssetsValuationAllowanceCurrent Deferred Tax Assets, Valuation Allowance, Current USD 274,736 2016-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap DeferredTaxAssetsValuationAllowanceNoncurrent Deferred Tax Assets, Valuation Allowance, Noncurrent USD 3.09M 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 182 2019-12-31 2020 FY 10-K 2021-03-31 0001437749-21-007756
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2023-12-31 2023 FY 10-K 2024-04-01 0000950170-24-039306
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 147,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap DepositAssets Deposit Assets USD 0 2022-12-31 2022 FY 10-K 2023-03-22 0001437749-23-007531
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 43,160 2013-09-30 2013 Q3 10-Q 2013-11-12 0001144204-13-060511
us-gaap Depreciation Depreciation USD 12,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 9,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD 670,943 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.18 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.209 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD -76,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.17M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 840,103 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 768,234 2018-03-31 2018 Q1 10-Q 2018-05-14 0001615774-18-003668
us-gaap EquitySecuritiesFVNINoncurrent EquitySecuritiesFVNINoncurrent USD 2.70M 2022-09-30 2022 Q3 10-Q 2022-11-07 0001437749-22-026178
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueAmount Equity Securities without Readily Determinable Fair Value, Amount USD 0 2024-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-276160
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-01-01 2017-06-30 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.5 2017-01-01 2017-06-30 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap FairValueInputsDiscountRate Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) pure 0.485 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap FiniteLivedComputerSoftwareGross Finite-Lived Computer Software, Gross (Deprecated 2013-01-31) USD 58,966 2013-03-31 2013 Q1 10-Q 2013-05-15 0001144204-13-029094
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 13,000 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 253,114 2017-09-30 2017 Q3 10-Q 2017-11-13 0001615774-17-006519
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 25,353 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 11,333 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 13,000 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 13,000 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 13,000 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 233,540 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap FiniteLivedLicenseAgreementsGross Finite-Lived License Agreements, Gross USD 0 2016-09-30 2016 Q3 10-Q 2016-11-14 0001144204-16-134190
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 1.63M 2016-09-30 2016 Q3 10-Q/A 2017-03-21 0001615774-17-001154
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -163,333 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001144204-16-099233
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD -163,333 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001144204-16-134190
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD -670,943 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 11.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap GrossProfit Gross Profit USD -130,653 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap HealthCareOrganizationMedicalSuppliesAndDrugsExpense Health Care Organization, Medical Supplies and Drugs Expense (Deprecated 2018-01-31) USD 162,600 2014-09-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001144204-14-067164
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001437749-20-006155
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -1.70M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001615774-17-002259
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -23.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -6.02M 2018-01-01 2018-06-30 2018 Q2 10-Q/A 2018-11-13 0001615774-18-012549
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -2.16 2016-01-01 2016-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD -3.00M 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares -1.58 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 248 2009-04-30 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030427
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 626,011 2018-06-30 2018 Q2 10-Q/A 2018-11-13 0001615774-18-012549
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 7.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -76,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -7.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 173,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 3,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 246,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -149,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -126,031 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-28 0001437749-19-005927
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -2.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 564,374 2015-01-01 2015-06-30 2016 Q2 10-Q/A 2017-03-21 0001615774-17-001155
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -11,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -391,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -9,276 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 20,000 2020-05-01 2020-05-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -719,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -352,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -711,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 4,456 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064686
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 355,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -220,000 2016-01-01 2016-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD -220,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001144204-16-134190
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 20,650 2016-01-01 2016-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 54,000 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap InterestExpense Interest Expense USD 1,784 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030135
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 383 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-08-14 0001615774-17-004407
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 330 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-28 0001437749-19-005927
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018024
us-gaap InventoryNet Inventory, Net USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap InventoryWriteDown Inventory Write-down USD 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-12 0001144204-14-048899
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 745,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 84,539 2016-09-30 2016 Q3 10-Q 2016-11-14 0001144204-16-134190
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 12,000 2019-09-30 2019 Q3 10-Q 2019-11-13 0001437749-19-022613
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 12,400 2020-03-31 2020 Q1 10-Q 2020-05-13 0001437749-20-010514
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1,200 2021-09-30 2021 Q3 10-Q 2021-11-15 0001437749-21-026640
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1,000 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap Liabilities Liabilities USD 4.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 26.45M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap LiabilitiesCurrent Liabilities, Current USD 4.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap LineOfCreditFacilityInterestRateAtPeriodEnd Line of Credit Facility, Interest Rate at Period End pure 0.028 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018024
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 0 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018024
us-gaap LitigationSettlementAmount Litigation Settlement, Amount (Deprecated 2017-01-31) USD 1.80M 2016-08-03 2016-08-04 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap LitigationSettlementAmountAwardedFromOtherParty Litigation Settlement, Amount Awarded from Other Party USD 1.76M 2016-08-03 2016-08-04 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 0 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064686
us-gaap LossContingencyAccrualCarryingValueCurrent Loss Contingency, Accrual, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap LossContingencyAccrualCarryingValuePeriodIncreaseDecrease Loss Contingency Accrual, Period Increase (Decrease) USD -208,108 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001144204-14-067164
us-gaap LossContingencyDamagesPaidValue Loss Contingency, Damages Paid, Value USD 3.50M 2018-03-23 2019 FY 10-K 2020-03-26 0001437749-20-006155
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 211,493 2009-04-30 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030427
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 206,336 2016-09-30 2016 Q3 10-Q 2016-11-14 0001144204-16-134190
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 4.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.87M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001615774-17-004407
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -9,213 2016-01-01 2016-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -24.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -3.21M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001615774-17-004407
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -23.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -6.28M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001437749-23-014366
us-gaap NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1 Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued shares 900,488 2017-01-01 2017-06-30 2018 Q2 10-Q/A 2018-11-13 0001615774-18-012549
us-gaap NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 Noncash or Part Noncash Divestiture, Amount of Consideration Received USD 3,900 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-14 0001437749-18-020638
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 242 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001437749-18-020638
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 0 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018024
us-gaap NumberOfOperatingSegments Number of Operating Segments Segments 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap OperatingExpenses Operating Expenses USD 24.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -24.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 17,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 0 2022-12-31 2022 FY 10-K 2023-03-22 0001437749-23-007531
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 11,108 2019-12-31 2020 FY 10-K 2021-03-31 0001437749-21-007756
us-gaap OperatingLeasePayments Operating Lease, Payments USD 19,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2022-12-31 2022 FY 10-K 2023-03-22 0001437749-23-007531
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 73,200 2018-12-31 2018 FY 10-K 2019-03-28 0001437749-19-005927
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 43,920 2018-12-31 2018 FY 10-K 2019-03-28 0001437749-19-005927
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 29,280 2018-12-31 2018 FY 10-K 2019-03-28 0001437749-19-005927
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2013-12-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030427
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 7,395 2017-09-30 2017 Q3 10-Q 2017-11-13 0001615774-17-006519
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 31,500 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001437749-20-006155
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.113 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap OptionIndexedToIssuersEquityIndexedShares Option Indexed to Issuer's Equity, Indexed Shares shares 325,000 2012-09-30 2014 Q1 10-Q 2014-05-14 0001144204-14-030427
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 106,802 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064686
us-gaap OtherAssetsCurrent Other Assets, Current USD 7,000 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -54,000 2022-07-01 2022-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 149,174 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 745,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap OtherNonoperatingGainsLosses Other Nonoperating Gains (Losses) USD -49,910 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030135
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 133,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 227,996 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044099
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 501,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0001437749-23-007531
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap PaymentsToAcquireFurnitureAndFixtures Payments to Acquire Furniture and Fixtures USD 54,448 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001437749-18-020638
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 15,553 2015-01-01 2015-09-30 2016 Q3 10-Q/A 2017-03-21 0001615774-17-001154
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap PaymentsToAcquireSoftware Payments to Acquire Software USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 11.48M 2018-01-01 2018-06-30 2018 Q2 10-Q/A 2018-11-13 0001615774-18-012549
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 577 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 577 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap PrepaidAdvertising Prepaid Advertising USD 20,000 2016-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap PrepaidInsurance Prepaid Insurance USD 76,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap PrepaidRent Prepaid Rent USD 0 2022-12-31 2022 FY 10-K 2023-03-22 0001437749-23-007531
us-gaap PrepaidTaxes Prepaid Taxes USD 0 2013-12-31 2013 FY 10-K 2014-03-27 0001144204-14-018247
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 6.16M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 12.29M 2018-01-01 2018-06-30 2018 Q2 10-Q/A 2018-11-13 0001615774-18-012549
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 4.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 3.87M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD 0 2009-05-01 2013-12-31 2013 FY 10-K 2014-03-27 0001144204-14-018247
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD -2,000 2009-04-30 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030427
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0001437749-23-007531
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -15.76M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 36,000 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 20,000 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 562,694 2015-01-01 2015-06-30 2016 Q2 10-Q/A 2017-03-21 0001615774-17-001155
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 49,215 2015-01-01 2015-09-30 2016 Q3 10-Q/A 2017-03-21 0001615774-17-001154
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 13.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 110,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 110,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -270.28M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 50,000 2015-12-15 2015-12-16 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap SaleOfStockPercentageOfOwnershipAfterTransaction Sale of Stock, Percentage of Ownership after Transaction pure 0.19 2015-12-15 2015-12-16 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 1,758 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 1,758 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 1.87M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030135
us-gaap SecurityDeposit Security Deposit USD 78,958 2014-09-30 2014 Q3 10-Q 2014-11-12 0001144204-14-067164
us-gaap SellingExpense Selling Expense USD 1.42M 2015-01-01 2015-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 12,709 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-14 0001144204-13-045866
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1.30M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-14 0001144204-13-045866
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 1.47M 2013-06-30 2013 Q2 10-Q 2013-08-14 0001144204-13-045866
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 339,199 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-14 0001144204-13-045866
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 5 2012-09-30 2014 Q1 10-Q 2014-05-14 0001144204-14-030427
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.05 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.89 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.027 2018-01-01 2018-06-30 2018 Q2 10-Q/A 2018-11-13 0001615774-18-012549
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.041 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 1.25 2018-01-01 2018-06-30 2018 Q2 10-Q/A 2018-11-13 0001615774-18-012549
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 152,031 2018-01-01 2018-06-30 2018 Q2 10-Q/A 2018-11-13 0001615774-18-012549
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 670,000 2021-03-31 2021 Q1 10-Q 2021-05-14 0001437749-21-012213
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.37M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 21.84 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 2.75M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 890 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value USD/shares 69.15 2016-01-01 2016-12-31 2016 FY 10-K/A 2017-03-21 0001615774-17-001151
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 97,055 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 63,334 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 239,196 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 20.96 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 520 2018-03-31 2018 Q1 10-Q 2018-05-14 0001615774-18-003668
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 20.96 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 710.1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 21.49 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 9.05 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap SharePrice Share Price USD/shares 0.5 2017-06-30 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 26,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 21.74M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.067 2026-02-02 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap StockIssued1 Stock Issued USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 862,500 2012-01-01 2012-09-30 2014 Q3 10-Q 2014-11-12 0001144204-14-067164
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 125,000 2017-06-29 2018 FY 10-K 2019-03-28 0001437749-19-005927
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 22,728 2014-05-01 2014-05-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan Stock Issued During Period, Value, Employee Stock Ownership Plan USD 200,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001144204-14-067164
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 4.29M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001144204-15-030135
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 0 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091380
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 3.67M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 198,523 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-08 0001615774-18-001693
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 4.31M 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-27 0001144204-14-018247
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 50,000 2014-05-01 2014-05-31 2014 FY 10-K 2015-03-30 0001144204-15-019344
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 547,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.72M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0001437749-23-007531
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 4.10M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001437749-23-031424
us-gaap SubsidiaryOrEquityMethodInvesteeDeferredIncomeTaxProvisionOnCumulativeGainLossRecognizedAmount Subsidiary or Equity Method Investee, Deferred Income Tax Provision on Gain (Loss) Recognized, Amount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap Supplies Prepaid Supplies USD 10,481 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064686
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 88,003 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 1.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 1.48M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044099
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124396
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 4.90M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044099
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 9.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 116,950 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001437749-22-004614
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 9.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454468

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →